Renalytix to Present at Stifel Healthcare Conference
November 03 2022 - 7:00AM
Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the
Company will participate in the Stifel Healthcare Conference to be
held November 15-16, 2022 at the Lotte New York Palace Hotel.
Interested parties may access a live and archived webcast of the
presentation on the “Investors” section of the Company’s website at
https://investors.renalytix.com or via the webcast registration
link below beginning at 3:35 p.m. Eastern Time on November 16,
2022.
Webcast registration link:
https://wsw.com/webcast/stifel74/rnlx/2129288
About RenalytixRenalytix (LSE:
RENX) (NASDAQ: RNLX) is the global founder and leader in the new
field of bioprognosis™ for kidney health. The company has
engineered a new solution that enables early-stage chronic kidney
disease progression risk assessment. The Company’s lead product,
KidneyIntelX™, has been granted Breakthrough Designation by the
U.S. Food and Drug Administration and is designed to help make
significant improvements in kidney disease prognosis, transplant
management, clinical care, patient stratification for drug clinical
trials, and drug target discovery
(visit www.kidneyintelx.com). For more information,
visit www.renalytix.com.
For further information, please contact:
Renalytix plc |
www.renalytix.com |
James McCullough, CEO |
Via Walbrook PR |
|
|
Stifel (Nominated Adviser, Joint Broker) |
Tel: 020 7710 7600 |
Alex Price / Nicholas Moore |
|
|
|
Investec Bank plc (Joint Broker) |
Tel: 020 7597 4000 |
Gary Clarence / Daniel Adams |
|
|
|
Walbrook PR Limited |
Tel: 020 7933 8780
or renalytix@walbrookpr.com |
Paul McManus / Lianne Applegarth / Alice Woodings |
Mob: 07980 541 893 / 07584 391 303 / 07407 804 654 |
|
|
CapComm Partners |
Tel: 415-389-6400 or investors@renalytix.com |
Peter DeNardo |
|
Renalytix (NASDAQ:RNLX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Renalytix (NASDAQ:RNLX)
Historical Stock Chart
From Apr 2023 to Apr 2024